title: Intravenous Antibiotics Used in the Treatment of Methicillin-Resistant Staphylococcus Aureus.
abstract: Methicillin-resistant Staphylococcus aureus (MRSA) continues to cause significant morbidity and mortality. Despite advances in medical care, the prevalence of both community-acquired and hospital-acquired MRSA has progressively increased. Community-acquired MRSA typically occurs in patients without recent illness or hospitalization, presents as acute skin and soft tissue infections, and is usually not multidrug resistant. Hospital-acquired MRSA, however, presents in patients recently hospitalized or treated in long-term care settings and in those who have had medical procedures and is usually associated with multidrug-resistant strains. Both types of infections, if not properly treated, have the potential to become invasive. This article discusses current intravenous antibiotics that are available for the empiric treatment of MRSA infections along with a newer phenomenon known as the "seesaw effect."
authors.affiliation: Kristine Anne Scordo is Professor and Director, Adult-Gerontology Acute Care Nurse Practitioner Program, College of Nursing, Wright State University, Dayton, OH 45435 (kscordo@cinci.rr.com).
authors.forename: Kristine Anne
authors.initials: KA
authors.lastname: Scordo
mesh_terms: D061605:Administration, Intravenous; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D008712:Methicillin / Q000627:therapeutic use*; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects*; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D008712:Methicillin